Department of Medicine V, Heidelberg University, Heidelberg, Germany.
Institute of Pathology, Heidelberg University, Heidelberg, Germany.
Biol Blood Marrow Transplant. 2018 Jun;24(6):1281-1288. doi: 10.1016/j.bbmt.2018.01.007. Epub 2018 Jan 17.
Successful collection of peripheral blood stem cells (PBSCs) depends on the optimal orchestration of mobilization chemotherapy, granulocyte colony stimulating factor (G-CSF) application, and CD34 cell number assessment in the peripheral blood (PB). However, determining the optimal timing in accordance to the applied chemomobilization regimen can be challenging. Although most centers apply their own local timing schedules, a reliable timetable including the currently most often used mobilization regimens is lacking. We present a comprehensive analysis of the timing modalities for 11 of the most commonly used chemomobilization regimens. A retrospective analysis was performed on the clinical and PBSC collection parameters (including duration of G-CSF application, time point of CD34 assessment, PB CD34 cell count, number of leukapheresis [LP] sessions, processed blood volume, and CD34 collection results) of 91 representatively selected patients who had undergone stem cell mobilization at 2 collection centers. Six to 10 patients were analyzed per regimen with a variety of diagnoses, including multiple myeloma, malignant lymphoma, and sarcoma. No collection failures (<2 × 10 CD34 cells/kg body weight) were observed. All analyzed patients successfully reached their individual collection goal in adherence to the given schedule of chemotherapy, application of G-CSF, measurement of CD34 cells, and subsequent LP. The presented data on the timing of chemomobilization, G-CSF application, and stem cell collection may be helpful in clinical decision making and contribute to a more transparent and predictable treatment process.
成功采集外周血干细胞 (PBSC) 取决于动员化疗、粒细胞集落刺激因子 (G-CSF) 应用和外周血 (PB) 中 CD34 细胞数量评估的最佳协调。然而,根据所应用的化学动员方案确定最佳时机可能具有挑战性。尽管大多数中心都采用自己的本地时间表,但缺乏包括当前最常用的动员方案在内的可靠时间表。我们对 11 种最常用的化学动员方案的时间模式进行了全面分析。对在 2 个采集中心进行干细胞动员的 91 名代表性选择患者的临床和 PBSC 采集参数(包括 G-CSF 应用持续时间、CD34 评估时间点、PB CD34 细胞计数、白细胞分离术 [LP] 次数、处理的血液量和 CD34 采集结果)进行了回顾性分析。每个方案分析了 6 到 10 名具有多种诊断的患者,包括多发性骨髓瘤、恶性淋巴瘤和肉瘤。未观察到采集失败 (<2 × 10 CD34 细胞/kg 体重)。所有分析的患者均成功按照化疗、G-CSF 应用、CD34 细胞测量和随后的 LP 时间表达到各自的采集目标。关于化学动员、G-CSF 应用和干细胞采集时间的提供的数据可能有助于临床决策,并有助于更透明和可预测的治疗过程。